Article
Rifampicin tolerance and growth fitness among isoniazid-resistant clinical <i>Mycobacterium tuberculosis</i> isolates: an in-vitro longitudinal study
2023-11-22
Abstract excerpt
Antibiotic tolerance in Mycobacterium tuberculosis leads to less effective bacterial killing, poor treatment responses and resistant emergence. Therefore, we investigated the rifampicin tolerance of M. tuberculosis isolates, with or without pre-existing isoniazid-resistance. We determined the in-vitro rifampicin survival fraction by minimum duration of killing assay in isoniazid susceptible (IS, n=119) and resi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b68676e5-3bc4-588b-8829-5d81f4c2c37d
- DOI
- 10.1101/2023.11.22.568240
